KBYPF (Kobayashi Pharmaceutical Co) Total Stockholders Equity: $1,304 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KBYPF Kobayashi Pharmaceutical Co Ltd KBYPF
80 GF Score
Price $34.05
GF Value $29.29
! 6 Warning Signs
View Full Analysis

What is Kobayashi Pharmaceutical Co Total Stockholders Equity?

Kobayashi Pharmaceutical Co KBYPF -2.71% 80 Total Stockholders Equity is $1,304 Mil as of Jun. 2026. GuruFocus rates KBYPF with a GF Score™ of 80/100 and a GF Value™ of $29.29. The stock has 6 warning signs investors should review.

Kobayashi Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $1,304 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Kobayashi Pharmaceutical Co's Book Value per Share for the quarter that ended in Jun. 2026 was $17.54. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Kobayashi Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.

Kobayashi Pharmaceutical Co  (OTCPK:KBYPF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Kobayashi Pharmaceutical Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1304.267-0)/74.339
=17.54

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Kobayashi Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.686 + 2.811) / 1304.267
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Total Stockholders Equity Related Terms

Kobayashi Pharmaceutical Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kobayashi Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Total Stockholders Equity Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,718.30 1,466.84 1,422.52 1,387.82 1,353.30

Kobayashi Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,441.28 1,434.00 1,353.30 1,316.56 1,304.27
KBYPF
80GF Score
Kobayashi Pharmaceutical Co Ltd KBYPF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $1,304 Mil mean?
Kobayashi Pharmaceutical Co (KBYPF) has a Total Stockholders Equity of $1,304 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Kobayashi Pharmaceutical Co and its competitors.
Is Kobayashi Pharmaceutical Co's Total Stockholders Equity too high?
Kobayashi Pharmaceutical Co's current Total Stockholders Equity is $1,304 Mil. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Total Stockholders Equity compare to PG and CL?
Kobayashi Pharmaceutical Co's Total Stockholders Equity of $1,304 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Consumer Packaged Goods company?
A good Total Stockholders Equity depends on the Consumer Packaged Goods industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Total Stockholders Equity is $1,304 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (KBYPF) has a current Total Stockholders Equity of $1,304 Mil. The stock's GF Value™ is $29.29, compared to a current price of $34.05 — trading 16.3% above its estimated fair value. The current Total Stockholders Equity is $1,304 Mil. Kobayashi Pharmaceutical Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (KBYPF), the current Total Stockholders Equity is $1,304 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kobayashi Pharmaceutical Co (KBYPF) Overvalued in 2026?

Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be overvalued. The current stock price of $34.05 is trading 16.3% above its estimated GF Value™ of $29.29.

Key valuation signals for KBYPF:

  • Total Stockholders Equity: $1,304 Mil
  • GF Value™: $29.29 vs. price of $34.05 (16.3% above fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the KBYPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kobayashi Pharmaceutical Co Business Description

Other Exchanges 4967:Japan
Address 4-4-10 Doshomachi, KDX Kobayashi Doshomachi Building, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
80GF Score

Get the complete analysis for KBYPF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.05
Price
$29.29
GF Value